Michael Metschl
About Michael Metschl
Michael Metschl is a Therapeutics Analyst based in New York, New York, with extensive experience in the financial and healthcare sectors. He has worked at Orbimed since 2017 and previously held positions at Citi and Orbimed in various analytical roles.
Current Role as Therapeutics Analyst
Michael Metschl currently serves as a Therapeutics Analyst at OrbiMed Advisors, a position he has held since 2017. In this role, he focuses on analyzing therapeutic investments and market trends within the healthcare sector. His expertise contributes to the firm's strategic decision-making and investment strategies.
Previous Experience at OrbiMed Advisors
Prior to his current role, Michael Metschl worked at OrbiMed Advisors from 2010 to 2013 as an Associate Analyst. He returned to the firm in 2014 as a Senior Associate, where he remained until 2016. His tenure at OrbiMed has provided him with extensive experience in the healthcare investment landscape.
Experience in Investment Banking at Citi
Before joining OrbiMed, Michael Metschl worked as an Investment Banking Analyst at Citi from 2008 to 2010. During this period, he gained valuable experience in financial analysis and investment strategies, which laid the groundwork for his subsequent roles in healthcare investment.
Educational Background at University of Notre Dame
Michael Metschl earned a Bachelor of Business Administration from the University of Notre Dame, completing his studies from 2004 to 2008. This educational background provided him with a solid foundation in business principles, which he has applied throughout his career in finance and investment.